While animal studies consistently demonstrate beneficial effects across diverse injury models and tissue types, the absence of adequately powered, controlled human clinical trials prevents definitive conclusions about efficacy in human disease
tirzepatide is a single molecule that adds the GIP pathway
This product is intended strictly for in vitro research ONLY and is NOT approved for human use, clinical application, or human consumption
Therapeutic dosing usually involves Vitamin B12 doses of 1000 mcg or more per day
[DOI] [PubMed] [Google Scholar] 86.Gregory S.G., Connelly J.J., Towers A.J., Johnson J., Biscocho D., Markunas C.A., Lintas C., Abramson R.K., Wright H.H., Ellis P., et al
Scientists first became interested in this peptide because of its potential influence on the bodys longevity mechanisms